 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||||||||| HR091506 / Jiangsu Hengrui Pharma
New P3 trial: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults (clinicaltrials.gov) - May 15, 2024
P3, N=434, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
- ||||| HR091506 / Jiangsu Hengrui Pharma
Trial completion date, Trial initiation date, Trial primary completion date: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults (clinicaltrials.gov) - Dec 31, 2023
P3, N=750, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
- |||||||||| HR091506 / Jiangsu Hengrui Pharma
New P3 trial: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults (clinicaltrials.gov) - Nov 18, 2023
P3, N=750, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
- ||| HR091506 / Jiangsu Hengrui Pharma
New P1 trial: A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults (clinicaltrials.gov) - Apr 25, 2022
P1, N=90, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.